These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30877211)

  • 21. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.
    Prince FH; Geerdink LM; Borsboom GJ; Twilt M; van Rossum MA; Hoppenreijs EP; Cate RT; Koopman-Keemink Y; van Santen-Hoeufft M; Raat H; van Suijlekom-Smit LW
    Ann Rheum Dis; 2010 Jan; 69(1):138-42. PubMed ID: 19581280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study.
    Oliveira S; Ravelli A; Pistorio A; Castell E; Malattia C; Prieur AM; Saad-Magalhães C; Murray KJ; Bae SC; Joos R; Foeldvari I; Duarte-Salazar C; Wulffraat N; Lahdenne P; Dolezalova P; de Inocencio J; Kanakoudi-Tsakalidou F; Hofer M; Nikishina I; Ozdogan H; Hashkes PJ; Landgraf JM; Martini A; Ruperto N;
    Arthritis Rheum; 2007 Feb; 57(1):35-43. PubMed ID: 17266064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort.
    Arnstad ED; Glerup M; Rypdal V; Peltoniemi S; Fasth A; Nielsen S; Zak M; Aalto K; Berntson L; Nordal E; Herlin T; Romundstad PR; Rygg M;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):33. PubMed ID: 33736650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis.
    Taxter AJ; Wileyto EP; Behrens EM; Weiss PF
    J Rheumatol; 2015 Oct; 42(10):1914-21. PubMed ID: 26329337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of health-related quality of life impairment in Egyptian children and adolescents with juvenile idiopathic arthritis: Sharkia Governorate.
    Abdul-Sattar AB; Elewa EA; El-Shahawy Eel-D; Waly EH
    Rheumatol Int; 2014 Aug; 34(8):1095-101. PubMed ID: 24469640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of health-related quality of life in children newly diagnosed with juvenile idiopathic arthritis.
    Seid M; Huang B; Niehaus S; Brunner HI; Lovell DJ
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):263-9. PubMed ID: 23983144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis.
    Tollisen A; Flatø B; Selvaag AM; Aasland A; Ingebrigtsen T; Sagen J; Lerdal A
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):221-231. PubMed ID: 31758669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health related quality of life survey about children and adolescents with juvenile idiopathic arthritis.
    Amine B; Rostom S; Benbouazza K; Abouqal R; Hajjaj-Hassouni N
    Rheumatol Int; 2009 Jan; 29(3):275-9. PubMed ID: 18690442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
    Ringold S; Wallace CA; Rivara FP
    J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
    Tarkiainen M; Tynjälä P; Vähäsalo P; Kröger L; Aalto K; Lahdenne P
    Pediatr Rheumatol Online J; 2019 Dec; 17(1):80. PubMed ID: 31842940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial.
    Bingham CO; Weinblatt M; Han C; Gathany TA; Kim L; Lo KH; Baker D; Mendelsohn A; Westhovens R
    J Rheumatol; 2014 Jun; 41(6):1067-76. PubMed ID: 24786931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does removal of aids/devices and help make a difference in the Childhood Health Assessment Questionnaire disability index?
    Saad-Magalhães C; Pistorio A; Ravelli A; Filocamo G; Viola S; Brik R; Mihaylova D; Cate RT; Andersson-Gare B; Ferriani V; Minden K; Hashkes P; Rygg M; Sauvain MJ; Venning H; Martini A; Ruperto N;
    Ann Rheum Dis; 2010 Jan; 69(1):82-7. PubMed ID: 19221399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of disease activity, functional disability and articular damage in patients with juvenile idiopathic arthritis: a prospective outcome study.
    Susic GZ; Stojanovic RM; Pejnovic NN; Damjanov NS; Soldatovic II; Jablanovic DB; Sefik Bukilica MN
    Clin Exp Rheumatol; 2011; 29(2):337-44. PubMed ID: 21385554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological intervention for adolescents with juvenile idiopathic arthritis: for whom and when?
    Fuchs CE; Van Geelen SM; Hermans HJ; Van De Putte EM; Van Geel R; Sinnema G; Kuis W
    J Rheumatol; 2013 Apr; 40(4):528-34. PubMed ID: 23418381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt.
    Mourão AF; Santos MJ; Melo Gomes JA; Martins FM; Mendonça SC; Oliveira Ramos F; Fernandes S; Salgado M; Guedes M; Carvalho S; Costa JA; Brito I; Duarte C; Furtado C; Lopes A; Rodrigues A; Sequeira G; Branco JC; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2016 Apr; 55(4):697-703. PubMed ID: 26672905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.
    Nalbanti P; Kanakoudi-Tsakalidou F; Trachana M; Pratsidou-Gertsi P; Farmaki E; Bamidis P; Papachristou F
    Rheumatol Int; 2018 Jul; 38(7):1241-1250. PubMed ID: 29845429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is time a healer? How quality of life changes over time reported by parents of children and young people with juvenile idiopathic arthritis.
    Smith AD; Saqib B; Lee RR; Shoop-Worrall S; Hyrich KL; McDonagh JE; Cordingley L
    Rheumatology (Oxford); 2023 Feb; 62(2):794-803. PubMed ID: 35608307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-rated physical and psychosocial health in a cohort of young adults with juvenile idiopathic arthritis.
    Ostile IL; Johansson I; Aasland A; Flatö B; Möller A
    Scand J Rheumatol; 2010 Aug; 39(4):318-25. PubMed ID: 20476866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.
    Strand V; Rentz AM; Cifaldi MA; Chen N; Roy S; Revicki D
    J Rheumatol; 2012 Jan; 39(1):63-72. PubMed ID: 22045836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
    Relas H; Kosola S
    Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.